Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

370 ARTÍCULOS , VIENDO DEL 226 AL 240

Neuroprotective Activity of Sitagliptin via Reduction of Neuroinflammation beyond the Incretin Effect: Focus on Alzheimer's Disease

Wiciński M, Wódkiewicz E, Słupski M, Walczak M, Socha M, Malinowski B, Pawlak-Osińska K.

Biomed Res Int. 2018 Aug 16;2018:6091014. doi: 10.1155/2018/6091014. eCollection 2018.

Alzheimer's Disease: A Review from the Pathophysiology to Diagnosis, New Perspectives for Pharmacological Treatment

Dos Santos Picanco LC, Ozela PF, de Fatima de Brito Brito M, Pinheiro AA, Padilha EC, Braga FS, de Paula da Silva CHT, Dos Santos CBR, Rosa JMC, da Silva Hage-Melim LI.

Curr Med Chem. 2018;25(26):3141-3159. doi: 10.2174/0929867323666161213101126.

Sex and gender in Alzheimer's disease - Does it matter?

Mielke MM, Ferretti MT, Iulita MF, Hayden K, Khachaturian AS.

Alzheimers Dement. 2018 Sep;14(9):1101-1103. doi: 10.1016/j.jalz.2018.08.003.

A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease

O'Bryant SE, Zhang F, Johnson LA, Hall J, Edwards M, Grammas P, Oh E, Lyketsos CG, Rissman RA.

J Alzheimers Dis. 2018;66(1):97-104. doi: 10.3233/JAD-180619.

Heat Shock Proteins in Alzheimer's Disease: Role and Targeting

Campanella C, Pace A, Caruso Bavisotto C, Marzullo P, Marino Gammazza A, Buscemi S, Palumbo Piccionello A.

Int J Mol Sci. 2018 Sep 1;19(9):2603. doi: 10.3390/ijms19092603.

The Biology of Glial Cells and Their Complex Roles in Alzheimer's Disease: New Opportunities in Therapy

Nirzhor SSR, Khan RI, Neelotpol S.

Biomolecules. 2018 Sep 10;8(3):93. doi: 10.3390/biom8030093.

The Gut-Brain Axis in Alzheimer's Disease and Omega-3. A Critical Overview of Clinical Trials

La Rosa F, Clerici M, Ratto D, Occhinegro A, Licito A, Romeo M, Iorio CD, Rossi P.

Nutrients. 2018 Sep 8;10(9):1267. doi: 10.3390/nu10091267.

The effect of physical exercise on cerebral blood flow in Alzheimer's disease

van der Kleij LA, Petersen ET, Siebner HR, Hendrikse J, Frederiksen KS, Sobol NA, Hasselbalch SG, Garde E.

Neuroimage Clin. 2018 Sep 4;20:650-654. doi: 10.1016/j.nicl.2018.09.003. eCollection 2018.

The efficacy and safety of memantine for the treatment of Alzheimer's disease

Matsunaga S, Kishi T, Nomura I, Sakuma K, Okuya M, Ikuta T, Iwata N.

Expert Opin Drug Saf. 2018 Oct;17(10):1053-1061. doi: 10.1080/14740338.2018.1524870. Epub 2018 Sep 26.

Rollercoaster ride of kynurenines: steering the wheel towards neuroprotection in Alzheimer's disease

Sharma R, Razdan K, Bansal Y, Kuhad A.

Expert Opin Ther Targets. 2018 Oct;22(10):849-867. doi: 10.1080/14728222.2018.1524877. Epub 2018 Sep 25.

Reducing disability via a family centered intervention for acutely ill persons with Alzheimer's disease and related dementias: protocol of a cluster-randomized controlled trial (Fam-FFC study)

Boltz M, Kuzmik A, Resnick B, Trotta R, Mogle J, BeLue R, Leslie D, Galvin JE.

Trials. 2018 Sep 17;19(1):496. doi: 10.1186/s13063-018-2875-1.

The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease

Neumann U, Ufer M, Jacobson LH, Rouzade-Dominguez ML, Huledal G, Kolly C, Lüönd RM, Machauer R, Veenstra SJ, Hurth K, Rueeger H, Tintelnot-Blomley M, Staufenbiel M, Shimshek DR, Perrot L, Frieauff W, Dubost V, Schiller H, Vogg B, Beltz K, Avrameas A, Kretz S, Pezous N, Rondeau JM, Beckmann N, Hartmann A, Vormfelde S, David OJ, Galli B, Ramos R, Graf A, Lopez Lopez C.

EMBO Mol Med. 2018 Nov;10(11):e9316. doi: 10.15252/emmm.201809316.

Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)

Salloway S, Honigberg LA, Cho W, Ward M, Friesenhahn M, Brunstein F, Quartino A, Clayton D, Mortensen D, Bittner T, Ho C, Rabe C, Schauer SP, Wildsmith KR, Fuji RN, Suliman S, Reiman EM, Chen K, Paul R.

Alzheimers Res Ther. 2018 Sep 19;10(1):96. doi: 10.1186/s13195-018-0424-5.

Physical activity can improve cognition in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials

Du Z, Li Y, Li J, Zhou C, Li F, Yang X.

Clin Interv Aging. 2018 Sep 4;13:1593-1603. doi: 10.2147/CIA.S169565. eCollection 2018.

Chinese Medicine for Alzheimer's Disease: A Meta-Analysis of Randomized Controlled Trials

Ma HK, Liu Y, Li B, Zhang Y, Sun LJ, Xu FQ.

Chin J Integr Med. 2018 Dec;24(12):938-943. doi: 10.1007/s11655-018-2567-4. Epub 2018 Sep 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias